Application 216984

Type
NDA
Sponsor
SHORLA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TEPYLUTETHIOTEPASOLUTION;INTRAVENOUS15MG/1.5ML (10MG/ML)YesYes
002TEPYLUTETHIOTEPASOLUTION;INTRAVENOUS100MG/10ML (10MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84373SUPPL 2026-04-20
84374SUPPL 2026-01-23
82187ORIG 2025-05-15
81378SUPPL 2025-02-27
81377SUPPL 2025-02-27
78903ORIG 2024-06-26